Literature DB >> 35707695

Estimating the turning point of the log-logistic hazard function in the presence of long-term survivors with an application for uterine cervical cancer data.

Patrick Borges1.   

Abstract

The hazard function plays an important role in cancer patient survival studies, as it quantifies the instantaneous risk of death of a patient at any given time. Often in cancer clinical trials, unimodal hazard functions are observed, and it is of interest to detect (estimate) the turning point (mode) of hazard function, as this may be an important measure in patient treatment strategies with cancer. Moreover, when patient cure is a possibility, estimating cure rates at different stages of cancer, in addition to their proportions, may provide a better summary of the effects of stages on survival rates. Therefore, the main objective of this paper is to consider the problem of estimating the mode of hazard function of patients at different stages of cervical cancer in the presence of long-term survivors. To this end, a mixture cure rate model is proposed using the log-logistic distribution. The model is conveniently parameterized through the mode of the hazard function, in which cancer stages can affect both the cured fraction and the mode. In addition, we discuss aspects of model inference through the maximum likelihood estimation method. A Monte Carlo simulation study assesses the coverage probability of asymptotic confidence intervals.
© 2020 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  Turning point; cured fraction; hazard function; log-logistic distribution; uterine cervical cancer

Year:  2020        PMID: 35707695      PMCID: PMC9041779          DOI: 10.1080/02664763.2020.1720627

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  7 in total

1.  Bootstrap confidence intervals for the mode of the hazard function.

Authors:  Josmar Mazucheli; Emílio Augusto Coelho Barros; Jorge Alberto Achcar
Journal:  Comput Methods Programs Biomed       Date:  2005-07       Impact factor: 5.428

2.  Estimating and modeling the cure fraction in population-based cancer survival analysis.

Authors:  Paul C Lambert; John R Thompson; Claire L Weston; Paul W Dickman
Journal:  Biostatistics       Date:  2006-10-04       Impact factor: 5.899

3.  Testing for the presence of immune or cured individuals in censored survival data.

Authors:  R A Maller; S Zhou
Journal:  Biometrics       Date:  1995-12       Impact factor: 2.571

4.  Hazard rate estimation under random censoring with varying kernels and bandwidths.

Authors:  H G Müller; J L Wang
Journal:  Biometrics       Date:  1994-03       Impact factor: 2.571

5.  Survivorship analysis when cure is a possibility: a Monte Carlo study.

Authors:  A I Goldman
Journal:  Stat Med       Date:  1984 Apr-Jun       Impact factor: 2.373

6.  Survival analysis of women with cervical cancer treated at a referral hospital for oncology in Espírito Santo State, Brazil, 2000-2005.

Authors:  Keila Cristina Mascarello; Eliana Zandonade; Maria Helena Costa Amorim
Journal:  Cad Saude Publica       Date:  2013-04       Impact factor: 1.632

7.  Long-term survival of patients with breast cancer: a study of the curability of the disease.

Authors:  A O Langlands; S J Pocock; G R Kerr; S M Gore
Journal:  Br Med J       Date:  1979-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.